Changes in activity, speech, sleep, or the way a person moves are all examples of measurements that can be captured remotely using digital tools. If transformed into digital biomarkers, such remote measures could dramatically improve diagnosis and the testing of potential treatments in FTD. At the inaugural Holloway Summit in Miami, leaders in FTD research, industry, foundations, and technology discussed how to transform the tools already available into standardized digital biomarkers.